159 related articles for article (PubMed ID: 31536342)
1. Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer.
Kawaguchi M; Han X; Hisada T; Nishikawa S; Kano K; Ieda N; Aoki J; Toyama T; Nakagawa H
J Med Chem; 2019 Oct; 62(20):9254-9269. PubMed ID: 31536342
[TBL] [Abstract][Full Text] [Related]
2. Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP.
Carozza JA; Brown JA; Böhnert V; Fernandez D; AlSaif Y; Mardjuki RE; Smith M; Li L
Cell Chem Biol; 2020 Nov; 27(11):1347-1358.e5. PubMed ID: 32726585
[TBL] [Abstract][Full Text] [Related]
3. ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors-A STING in the Tale of ENPP1.
Onyedibe KI; Wang M; Sintim HO
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752288
[TBL] [Abstract][Full Text] [Related]
4. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.
Wang S; Böhnert V; Joseph AJ; Sudaryo V; Skariah G; Swinderman JT; Yu FB; Subramanyam V; Wolf DM; Lyu X; Gilbert LA; Van't Veer LJ; Goodarzi H; Li L
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2313693120. PubMed ID: 38117852
[TBL] [Abstract][Full Text] [Related]
5. Human antibodies targeting ENPP1 as candidate therapeutics for cancers.
Chu X; Baek DS; Li W; Shyp T; Mooney B; Hines MG; Morin GB; Sorensen PH; Dimitrov DS
Front Immunol; 2023; 14():1070492. PubMed ID: 36761762
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Pyrido[2,3-
Sun Y; Chen M; Han Y; Li W; Ma X; Shi Z; Zhou Y; Xu L; Yu L; Wang Y; Yu J; Diao X; Meng L; Xu S
J Med Chem; 2024 Mar; 67(5):3986-4006. PubMed ID: 38387074
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy.
Gangar M; Goyal S; Raykar D; Khurana P; Martis AM; Goswami A; Ghoshal I; Patel KV; Nagare Y; Raikar S; Mukherjee A; Cyriac R; Paquin JF; Kulkarni A
Bioorg Chem; 2022 Feb; 119():105549. PubMed ID: 34929517
[TBL] [Abstract][Full Text] [Related]
8. Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy.
Wang X; Lu X; Yan D; Zhou Y; Tan X
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806118
[TBL] [Abstract][Full Text] [Related]
9. Enpp1: a potential facilitator of breast cancer bone metastasis.
Lau WM; Doucet M; Stadel R; Huang D; Weber KL; Kominsky SL
PLoS One; 2013; 8(7):e66752. PubMed ID: 23861746
[TBL] [Abstract][Full Text] [Related]
10. Development of a High-Throughput Assay to Identify Inhibitors of ENPP1.
Kumar M; Lowery RG
SLAS Discov; 2021 Jun; 26(5):740-746. PubMed ID: 33402044
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1.
Kato K; Nishimasu H; Oikawa D; Hirano S; Hirano H; Kasuya G; Ishitani R; Tokunaga F; Nureki O
Nat Commun; 2018 Oct; 9(1):4424. PubMed ID: 30356045
[TBL] [Abstract][Full Text] [Related]
12. The role of ENPP1/PC-1 in osteoinduction by calcium phosphate ceramics.
Othman Z; Fernandes H; Groot AJ; Luider TM; Alcinesio A; Pereira DM; Guttenplan APM; Yuan H; Habibovic P
Biomaterials; 2019 Jul; 210():12-24. PubMed ID: 31048198
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.
Li L; Yin Q; Kuss P; Maliga Z; Millán JL; Wu H; Mitchison TJ
Nat Chem Biol; 2014 Dec; 10(12):1043-8. PubMed ID: 25344812
[TBL] [Abstract][Full Text] [Related]
14. Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.
Takahashi RU; Miyazaki H; Takeshita F; Yamamoto Y; Minoura K; Ono M; Kodaira M; Tamura K; Mori M; Ochiya T
Nat Commun; 2015 Jun; 6():7318. PubMed ID: 26065921
[TBL] [Abstract][Full Text] [Related]
15. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.
Ruiz-Fernández de Córdoba B; Moreno H; Valencia K; Perurena N; Ruedas P; Walle T; Pezonaga-Torres A; Hinojosa J; Guruceaga E; Pineda-Lucena A; Abengózar-Muela M; Cochonneau D; Zandueta C; Martínez-Canarias S; Teijeira Á; Ajona D; Ortiz-Espinosa S; Morales X; Ortiz de Solórzano C; Santisteban M; Ramos-García LI; Guembe L; Strnad V; Heymann D; Hervás-Stubbs S; Pío R; Rodríguez-Ruiz ME; de Andrea CE; Vicent S; Melero I; Lecanda F; Martínez-Monge R
Cancer Discov; 2022 May; 12(5):1356-1377. PubMed ID: 35191482
[TBL] [Abstract][Full Text] [Related]
16. The role of HSP70 on ENPP1 expression and insulin-receptor activation.
Marucci A; Miscio G; Padovano L; Boonyasrisawat W; Florez JC; Doria A; Trischitta V; Paola RD
J Mol Med (Berl); 2009 Feb; 87(2):139-144. PubMed ID: 19083193
[TBL] [Abstract][Full Text] [Related]
17. AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model.
Goswami A; Deb B; Goyal S; Gosavi A; Mali M; Martis AM; Khurana P; Gangar M; Raykar D; Mohanty A; Kulkarni A
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235254
[TBL] [Abstract][Full Text] [Related]
18. ENPP1 in Blood and Bone: Skeletal and Soft Tissue Diseases Induced by ENPP1 Deficiency.
Ferreira CR; Carpenter TO; Braddock DT
Annu Rev Pathol; 2024 Jan; 19():507-540. PubMed ID: 37871131
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue dysfunction in humans: a potential role for the transmembrane protein ENPP1.
Chandalia M; Davila H; Pan W; Szuszkiewicz M; Tuvdendorj D; Livingston EH; Abate N
J Clin Endocrinol Metab; 2012 Dec; 97(12):4663-72. PubMed ID: 23012391
[TBL] [Abstract][Full Text] [Related]
20. Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects.
Guan D; Fang L; Feng M; Guo S; Xie L; Chen C; Sun X; Wu Q; Yuan X; Xie Z; Zhou J; Zhang H
Eur J Med Chem; 2024 Mar; 267():116211. PubMed ID: 38359537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]